Cargando…

A Hrd way for MHC-II expression

Detalles Bibliográficos
Autores principales:	Melo-Cardenas, Johanna, Kong, Sinyi, Fang, Deyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673110/ https://www.ncbi.nlm.nih.gov/pubmed/26312567

Ejemplares similares

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation
por: Yang, Heeyoung, et al.
Publicado: (2014)

The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity
por: Xu, Yuanming, et al.
Publicado: (2016)

Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination
por: Cho, Kyung-Jin, et al.
Publicado: (2013)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes
por: Wei, Juncheng, et al.
Publicado: (2018)

The aging kidney is characterized by tubuloinflammaging, a phenotype associated with MHC-II gene expression
por: Sinning, Julius, et al.
Publicado: (2023)

Implementing HRD technology /
Publicado: (1999)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts
por: Wosen, Jonathan E., et al.
Publicado: (2018)

Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium
por: Gopalakrishnan, Shreya, et al.
Publicado: (2022)

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
por: Celesti, Fabrizio, et al.
Publicado: (2023)

New vistas unfold: Chicken MHC molecules reveal unexpected ways to present peptides to the immune system
por: Halabi, Samer, et al.
Publicado: (2022)

Antigen Processing for MHC Class II Presentation via Autophagy
por: Münz, Christian
Publicado: (2012)

Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions
por: Degoot, Abdoelnaser M., et al.
Publicado: (2018)

Human Intestinal Enteroids Model MHC-II in the Gut Epithelium
por: Wosen, Jonathan E., et al.
Publicado: (2019)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
por: Santambrogio, Laura
Publicado: (2022)

A Missing Switch in Peptide Exchange for MHC Class II Molecules
por: Freund, Christian, et al.
Publicado: (2019)

Haplotype-Specific Expression Analysis of MHC Class II Genes in Healthy Individuals and Rheumatoid Arthritis Patients
por: Houtman, Miranda, et al.
Publicado: (2021)

Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
por: Wu, Tongde, et al.
Publicado: (2014)

Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3
por: Schoebel, Stefan, et al.
Publicado: (2017)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022)

Profound N-glycan remodelling accompanies MHC-II immunopeptide presentation
por: Goodson, Hayley, et al.
Publicado: (2023)

Toward a Network Model of MHC Class II-Restricted Antigen Processing
por: Miller, Michael A., et al.
Publicado: (2013)

Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal
por: Ferrante, Andrea
Publicado: (2013)

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013)

Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4(+) T Cell Responses
por: Milillo, M. Ayelén, et al.
Publicado: (2019)

The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity?
por: Collado, Javier A., et al.
Publicado: (2013)

SEL1L-HRD1 ER-associated degradation suppresses hepatocyte hyperproliferation and liver cancer
por: Bhattacharya, Asmita, et al.
Publicado: (2022)

Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
por: Leung, Carol S. K.
Publicado: (2015)

Macroautophagy in Endogenous Processing of Self- and Pathogen-Derived Antigens for MHC Class II Presentation
por: Duraes, Fernanda V., et al.
Publicado: (2015)

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014)

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
por: James, Eddie A., et al.
Publicado: (2009)

Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome
por: Fortin, Jean-Simon, et al.
Publicado: (2013)

Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?
por: Pellegrino, Benedetta, et al.
Publicado: (2019)

Downregulation of MHC Class I Expression by Influenza A and B Viruses
por: Koutsakos, Marios, et al.
Publicado: (2019)

Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First
por: Wu, Yanan, et al.
Publicado: (2021)

MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis
por: Harrington, Em P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3uih7b10i8afoatf6ofprq0gko